Sign in
4

Changes in Ownership

RIGEL PHARMACEUTICALS INC Filed Acc 0000905148-24-003281

Options or other derivatives

  • EVP & Chief Financial Officer acquired 6,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Schorno Dean L · EVP & Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-11-25 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +6,250 6,250 D
Loading xslF345X05/form4.xml…